Pages

Sunday, January 19, 2014

(LML) Dapsone syndrome

Leprosy Mailing List – January 19,  2014 

Ref.:    (LML) DDS syndrome

From:  David M. Scollard,  Baton Rouge, Louisiana, USA


Dear Pieter,

Regarding the dapsone syndrome, the following article was published recently in the New England Journal of Medicine, describing a genetic association with this syndrome.  The research was done in China and it appears that individuals of Chinese ancestry may be more likely to carry the allele(s) that put them at risk for this syndrome.

Zhang F.-R., Liu H., Irwanto A., et al.

HLA-B*13:01 and the Dapsone Hypersensitivity Syndrome

N Engl J Med 2013; 369:1620-1628

Dapsone is an important medication for the treatment of leprosy, but a life-threatening drug hypersensitivity syndrome develops in some patients. In this report from China, an HLA-B locus is identified as a strong genetic risk factor for the syndrome.

 

Best wishes,

David

David M. Scollard, M.D., Ph.D.

Director

National Hansen’s Disease Programs

Tel:  225-756-3713 or 225-756-3776

Fax:  225-756-3819 (Clinical) or 225-756-3806 (Administration)

E-mail:  dscollard@hrsa.gov

Web:  www.hrsa.gov/hansens                 

Online Course:  http://www.hrsa.gov/hansensdisease/onlinecourseawareness.html

 


LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

 




This email is free from viruses and malware because avast! Antivirus protection is active.


No comments:

Post a Comment

Note: Only a member of this blog may post a comment.